Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-10-14

AUTHORS

Juan J Jiménez, José L Iribarren, Maitane Brouard, Domingo Hernández, Salomé Palmero, Alejandro Jiménez, Leonardo Lorente, Patricia Machado, Juan M Borreguero, José M Raya, Beatriz Martín, Rosalía Pérez, Rafael Martínez, María L Mora

ABSTRACT

BackgroundIn cardiopulmonary bypass (CPB) patients, fibrinolysis may enhance postoperative inflammatory response. We aimed to determine whether an additional postoperative dose of antifibrinolytic tranexamic acid (TA) reduced CPB-mediated inflammatory response (IR).MethodsWe performed a randomized, double-blind, dose-dependent, parallel-groups study of elective CPB patients receiving TA. Patients were randomly assigned to either the single-dose group (40 mg/Kg TA before CPB and placebo after CPB) or the double-dose group (40 mg/Kg TA before and after CPB).Results160 patients were included, 80 in each group. The incident rate of IR was significantly lower in the double-dose-group TA2 (7.5% vs. 18.8% in the single-dose group TA1; P = 0.030). After adjusting for hypertension, total protamine dose and temperature after CPB, TA2 showed a lower risk of IR compared with TA1 [OR: 0.29 (95% CI: 0.10-0.83), (P = 0.013)]. Relative risk for IR was 2.5 for TA1 (95% CI: 1.02 to 6.12). The double-dose group had significantly lower chest tube bleeding at 24 hours [671 (95% CI 549-793 vs. 826 (95% CI 704-949) mL; P = 0.01 corrected-P significant] and lower D-dimer levels at 24 hours [489 (95% CI 437-540) vs. 621(95% CI: 563-679) ng/mL; P = 0.01 corrected-P significant]. TA2 required lower levels of norepinephrine at 24 h [0.06 (95% CI: 0.03-0.09) vs. 0.20(95 CI: 0.05-0.35) after adjusting for dobutamine [F = 6.6; P = 0.014 corrected-P significant].We found a significant direct relationship between IL-6 and temperature (rho = 0.26; P < 0.01), D-dimer (rho = 0.24; P < 0.01), norepinephrine (rho = 0.33; P < 0.01), troponin I (rho = 0.37; P < 0.01), Creatine-Kinase (rho = 0.37; P < 0.01), Creatine Kinase-MB (rho = 0.33; P < 0.01) and lactic acid (rho = 0.46; P < 0.01) at ICU arrival. Two patients (1.3%) had seizure, 3 patients (1.9%) had stroke, 14 (8.8%) had acute kidney failure, 7 (4.4%) needed dialysis, 3 (1.9%) suffered myocardial infarction and 9 (5.6%) patients died. We found no significant differences between groups regarding these events.ConclusionsProlonged inhibition of fibrinolysis, using an additional postoperative dose of tranexamic acid reduces inflammatory response and postoperative bleeding (but not transfusion requirements) in CPB patients. A question which remains unanswered is whether the dose used was ideal in terms of safety, but not in terms of effectiveness.Current Controlled Trials numberISRCTN: ISRCTN84413719 More... »

PAGES

138

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1749-8090-6-138

DOI

http://dx.doi.org/10.1186/1749-8090-6-138

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012221471

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21999189


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antifibrinolytic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Temperature", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiopulmonary Bypass", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatine Kinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Creatine Kinase, MB Form", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Elective Surgical Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrin Fibrinogen Degradation Products", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrinolysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation Mediators", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-6", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Logistic Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norepinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Statistics, Nonparametric", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tranexamic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jim\u00e9nez", 
        "givenName": "Juan J", 
        "id": "sg:person.01076143405.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076143405.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iribarren", 
        "givenName": "Jos\u00e9 L", 
        "id": "sg:person.011703116655.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011703116655.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brouard", 
        "givenName": "Maitane", 
        "id": "sg:person.01323473101.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323473101.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nephrology Department, Hospital Universitario Carlos Haya, 29010, M\u00e1laga, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411457.2", 
          "name": [
            "Nephrology Department, Hospital Universitario Carlos Haya, 29010, M\u00e1laga, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hern\u00e1ndez", 
        "givenName": "Domingo", 
        "id": "sg:person.01317135435.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317135435.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmero", 
        "givenName": "Salom\u00e9", 
        "id": "sg:person.01262262305.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262262305.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mixed Research Unit, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Mixed Research Unit, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jim\u00e9nez", 
        "givenName": "Alejandro", 
        "id": "sg:person.01025307027.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025307027.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lorente", 
        "givenName": "Leonardo", 
        "id": "sg:person.01100400223.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100400223.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Machado", 
        "givenName": "Patricia", 
        "id": "sg:person.0624762302.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624762302.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borreguero", 
        "givenName": "Juan M", 
        "id": "sg:person.0673075502.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673075502.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raya", 
        "givenName": "Jos\u00e9 M", 
        "id": "sg:person.01256166004.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256166004.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00edn", 
        "givenName": "Beatriz", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "P\u00e9rez", 
        "givenName": "Rosal\u00eda", 
        "id": "sg:person.01255357701.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255357701.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiac Surgery Department, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Tenerife, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Cardiac Surgery Department, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Tenerife, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mart\u00ednez", 
        "givenName": "Rafael", 
        "id": "sg:person.011717357023.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011717357023.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411220.4", 
          "name": [
            "Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mora", 
        "givenName": "Mar\u00eda L", 
        "id": "sg:person.0770012723.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770012723.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00003495-199957060-00017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008076201", 
          "https://doi.org/10.2165/00003495-199957060-00017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc8153", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027376444", 
          "https://doi.org/10.1186/cc8153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc9216", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008087528", 
          "https://doi.org/10.1186/cc9216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-006-0478-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009668800", 
          "https://doi.org/10.1007/s00134-006-0478-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc6173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051032275", 
          "https://doi.org/10.1186/cc6173"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-10-14", 
    "datePublishedReg": "2011-10-14", 
    "description": "BackgroundIn cardiopulmonary bypass (CPB) patients, fibrinolysis may enhance postoperative inflammatory response. We aimed to determine whether an additional postoperative dose of antifibrinolytic tranexamic acid (TA) reduced CPB-mediated inflammatory response (IR).MethodsWe performed a randomized, double-blind, dose-dependent, parallel-groups study of elective CPB patients receiving TA. Patients were randomly assigned to either the single-dose group (40 mg/Kg TA before CPB and placebo after CPB) or the double-dose group (40 mg/Kg TA before and after CPB).Results160 patients were included, 80 in each group. The incident rate of IR was significantly lower in the double-dose-group TA2 (7.5% vs. 18.8% in the single-dose group TA1; P = 0.030). After adjusting for hypertension, total protamine dose and temperature after CPB, TA2 showed a lower risk of IR compared with TA1 [OR: 0.29 (95% CI: 0.10-0.83), (P = 0.013)]. Relative risk for IR was 2.5 for TA1 (95% CI: 1.02 to 6.12). The double-dose group had significantly lower chest tube bleeding at 24 hours [671 (95% CI 549-793 vs. 826 (95% CI 704-949) mL; P = 0.01 corrected-P significant] and lower D-dimer levels at 24 hours [489 (95% CI 437-540) vs. 621(95% CI: 563-679) ng/mL; P = 0.01 corrected-P significant]. TA2 required lower levels of norepinephrine at 24 h [0.06 (95% CI: 0.03-0.09) vs. 0.20(95 CI: 0.05-0.35) after adjusting for dobutamine [F = 6.6; P = 0.014 corrected-P significant].We found a significant direct relationship between IL-6 and temperature (rho = 0.26; P < 0.01), D-dimer (rho = 0.24; P < 0.01), norepinephrine (rho = 0.33; P < 0.01), troponin I (rho = 0.37; P < 0.01), Creatine-Kinase (rho = 0.37; P < 0.01), Creatine Kinase-MB (rho = 0.33; P < 0.01) and lactic acid (rho = 0.46; P < 0.01) at ICU arrival. Two patients (1.3%) had seizure, 3 patients (1.9%) had stroke, 14 (8.8%) had acute kidney failure, 7 (4.4%) needed dialysis, 3 (1.9%) suffered myocardial infarction and 9 (5.6%) patients died. We found no significant differences between groups regarding these events.ConclusionsProlonged inhibition of fibrinolysis, using an additional postoperative dose of tranexamic acid reduces inflammatory response and postoperative bleeding (but not transfusion requirements) in CPB patients. A question which remains unanswered is whether the dose used was ideal in terms of safety, but not in terms of effectiveness.Current Controlled Trials numberISRCTN: ISRCTN84413719", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1749-8090-6-138", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036453", 
        "issn": [
          "1749-8090"
        ], 
        "name": "Journal of Cardiothoracic Surgery", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "keywords": [
      "double-dose group", 
      "inflammatory response", 
      "tranexamic acid", 
      "total protamine dose", 
      "postoperative inflammatory response", 
      "parallel-group study", 
      "single-dose group", 
      "cardiopulmonary bypass patients", 
      "antifibrinolytic tranexamic acid", 
      "postoperative dose", 
      "CPB patients", 
      "bypass patients", 
      "chest tube", 
      "protamine dose", 
      "relative risk", 
      "lower risk", 
      "patients", 
      "incident rate", 
      "dose", 
      "CPB", 
      "risk", 
      "group", 
      "hypertension", 
      "fibrinolysis", 
      "MethodsWe", 
      "response", 
      "hours", 
      "TA1", 
      "study", 
      "rate", 
      "acid", 
      "tube", 
      "TA2", 
      "temperature"
    ], 
    "name": "Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial", 
    "pagination": "138", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012221471"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1749-8090-6-138"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21999189"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1749-8090-6-138", 
      "https://app.dimensions.ai/details/publication/pub.1012221471"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_529.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1749-8090-6-138"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1749-8090-6-138'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1749-8090-6-138'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1749-8090-6-138'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1749-8090-6-138'


 

This table displays all metadata directly associated to this object as RDF triples.

311 TRIPLES      21 PREDICATES      88 URIs      75 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1749-8090-6-138 schema:about N06eddca8d9ca441f890d6e6b95524d3a
2 N0aa8744500e941a08b8c276cc7c1001e
3 N0bd31d90651647ec9d2ba64e5aaeac9c
4 N0ed5dd5ec3b346ca9d144d08a41d4525
5 N10b6b2b91147443fb7076182c0365295
6 N16b646fa648d48a786602f82f8c8b08d
7 N1e026749e0cd48d88fdb8771a0818440
8 N244df86504c749f9abcb9f150580e317
9 N26760aea18c649c6bd2bcafaa3d4e6c2
10 N3c4a309881f640b7aaaa94c28c81c53d
11 N44fa8fe0df134e81934a593be6a4650b
12 N4af0da268df149ec9a47357089d821b6
13 N6106ba342f194cefbe8063e4ead3b396
14 N6200e302d6c94156a308cba3ec2d04f3
15 N72a264d6b85f42049dc89809a6031606
16 N7657580b204043c980bfb7e81558fbe0
17 N8d2da3d3b53b4505b8a59b641a36408c
18 N90105f56b16343dfbad55f0086ef2fac
19 N97e84c5bee1f4e2bb538c199f3c57f88
20 Na2945c88025b43cf80431adf38cddbf8
21 Naa36c2127adb493fb6da0770eefb8912
22 Naffadebc55ab4be781f60b8a43b2b052
23 Nb3330eecb3084a99986335874fab95bc
24 Nee214c85161a4a0ab161fb64ef6e1cb0
25 anzsrc-for:11
26 anzsrc-for:1103
27 schema:author Nceff78bc3b7549f786f88fefc2f39cdc
28 schema:citation sg:pub.10.1007/s00134-006-0478-x
29 sg:pub.10.1186/cc6173
30 sg:pub.10.1186/cc8153
31 sg:pub.10.1186/cc9216
32 sg:pub.10.2165/00003495-199957060-00017
33 schema:datePublished 2011-10-14
34 schema:datePublishedReg 2011-10-14
35 schema:description BackgroundIn cardiopulmonary bypass (CPB) patients, fibrinolysis may enhance postoperative inflammatory response. We aimed to determine whether an additional postoperative dose of antifibrinolytic tranexamic acid (TA) reduced CPB-mediated inflammatory response (IR).MethodsWe performed a randomized, double-blind, dose-dependent, parallel-groups study of elective CPB patients receiving TA. Patients were randomly assigned to either the single-dose group (40 mg/Kg TA before CPB and placebo after CPB) or the double-dose group (40 mg/Kg TA before and after CPB).Results160 patients were included, 80 in each group. The incident rate of IR was significantly lower in the double-dose-group TA2 (7.5% vs. 18.8% in the single-dose group TA1; P = 0.030). After adjusting for hypertension, total protamine dose and temperature after CPB, TA2 showed a lower risk of IR compared with TA1 [OR: 0.29 (95% CI: 0.10-0.83), (P = 0.013)]. Relative risk for IR was 2.5 for TA1 (95% CI: 1.02 to 6.12). The double-dose group had significantly lower chest tube bleeding at 24 hours [671 (95% CI 549-793 vs. 826 (95% CI 704-949) mL; P = 0.01 corrected-P significant] and lower D-dimer levels at 24 hours [489 (95% CI 437-540) vs. 621(95% CI: 563-679) ng/mL; P = 0.01 corrected-P significant]. TA2 required lower levels of norepinephrine at 24 h [0.06 (95% CI: 0.03-0.09) vs. 0.20(95 CI: 0.05-0.35) after adjusting for dobutamine [F = 6.6; P = 0.014 corrected-P significant].We found a significant direct relationship between IL-6 and temperature (rho = 0.26; P < 0.01), D-dimer (rho = 0.24; P < 0.01), norepinephrine (rho = 0.33; P < 0.01), troponin I (rho = 0.37; P < 0.01), Creatine-Kinase (rho = 0.37; P < 0.01), Creatine Kinase-MB (rho = 0.33; P < 0.01) and lactic acid (rho = 0.46; P < 0.01) at ICU arrival. Two patients (1.3%) had seizure, 3 patients (1.9%) had stroke, 14 (8.8%) had acute kidney failure, 7 (4.4%) needed dialysis, 3 (1.9%) suffered myocardial infarction and 9 (5.6%) patients died. We found no significant differences between groups regarding these events.ConclusionsProlonged inhibition of fibrinolysis, using an additional postoperative dose of tranexamic acid reduces inflammatory response and postoperative bleeding (but not transfusion requirements) in CPB patients. A question which remains unanswered is whether the dose used was ideal in terms of safety, but not in terms of effectiveness.Current Controlled Trials numberISRCTN: ISRCTN84413719
36 schema:genre article
37 schema:isAccessibleForFree true
38 schema:isPartOf N4b0dcd65b3e64cf0a68b5a5ffb9ae940
39 N5e67057334f94af882c03a87a9912cd2
40 sg:journal.1036453
41 schema:keywords CPB
42 CPB patients
43 MethodsWe
44 TA1
45 TA2
46 acid
47 antifibrinolytic tranexamic acid
48 bypass patients
49 cardiopulmonary bypass patients
50 chest tube
51 dose
52 double-dose group
53 fibrinolysis
54 group
55 hours
56 hypertension
57 incident rate
58 inflammatory response
59 lower risk
60 parallel-group study
61 patients
62 postoperative dose
63 postoperative inflammatory response
64 protamine dose
65 rate
66 relative risk
67 response
68 risk
69 single-dose group
70 study
71 temperature
72 total protamine dose
73 tranexamic acid
74 tube
75 schema:name Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial
76 schema:pagination 138
77 schema:productId N5f6595d38e3b4c29b2bfe4546ad9cc2d
78 Nae041eedf4de4649b5904f4e300d7326
79 Nb193b71e226f47a09ccf2dbb855d29e4
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012221471
81 https://doi.org/10.1186/1749-8090-6-138
82 schema:sdDatePublished 2022-12-01T06:28
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher Nf22c064d18db497a9f73462ec909e1c9
85 schema:url https://doi.org/10.1186/1749-8090-6-138
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N02a7e4f79166423a840f70b8a2451964 rdf:first sg:person.0624762302.45
90 rdf:rest N588e9b417e2e4bbe9ee0d4614bc9afe1
91 N06eddca8d9ca441f890d6e6b95524d3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Aged
93 rdf:type schema:DefinedTerm
94 N0aa8744500e941a08b8c276cc7c1001e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Elective Surgical Procedures
96 rdf:type schema:DefinedTerm
97 N0bd31d90651647ec9d2ba64e5aaeac9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Fibrin Fibrinogen Degradation Products
99 rdf:type schema:DefinedTerm
100 N0d92f5e3e9ad497cb39133fc3dcaedc1 rdf:first sg:person.01255357701.67
101 rdf:rest Ndd1554f9b9ee4ef0821bbbec7eff189a
102 N0ed5dd5ec3b346ca9d144d08a41d4525 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Logistic Models
104 rdf:type schema:DefinedTerm
105 N10b6b2b91147443fb7076182c0365295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cardiopulmonary Bypass
107 rdf:type schema:DefinedTerm
108 N16b646fa648d48a786602f82f8c8b08d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Female
110 rdf:type schema:DefinedTerm
111 N1e026749e0cd48d88fdb8771a0818440 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Middle Aged
113 rdf:type schema:DefinedTerm
114 N244df86504c749f9abcb9f150580e317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Humans
116 rdf:type schema:DefinedTerm
117 N26760aea18c649c6bd2bcafaa3d4e6c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Tranexamic Acid
119 rdf:type schema:DefinedTerm
120 N3c4a309881f640b7aaaa94c28c81c53d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Creatine Kinase
122 rdf:type schema:DefinedTerm
123 N42811ae879824b65a30e014fad757490 rdf:first sg:person.01323473101.00
124 rdf:rest N4867edcb4ea444749ba40b46d75687cf
125 N44fa8fe0df134e81934a593be6a4650b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Male
127 rdf:type schema:DefinedTerm
128 N4867edcb4ea444749ba40b46d75687cf rdf:first sg:person.01317135435.05
129 rdf:rest N7f3b60b95ef84395b630ed223142acd4
130 N4af0da268df149ec9a47357089d821b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Treatment Outcome
132 rdf:type schema:DefinedTerm
133 N4b0dcd65b3e64cf0a68b5a5ffb9ae940 schema:issueNumber 1
134 rdf:type schema:PublicationIssue
135 N4b6161cdba9d487d921b8dd5e26f2b11 rdf:first sg:person.01256166004.37
136 rdf:rest Ndb405738fb7e4be7addb5f6ad4e520c8
137 N588e9b417e2e4bbe9ee0d4614bc9afe1 rdf:first sg:person.0673075502.74
138 rdf:rest N4b6161cdba9d487d921b8dd5e26f2b11
139 N5e67057334f94af882c03a87a9912cd2 schema:volumeNumber 6
140 rdf:type schema:PublicationVolume
141 N5f6595d38e3b4c29b2bfe4546ad9cc2d schema:name dimensions_id
142 schema:value pub.1012221471
143 rdf:type schema:PropertyValue
144 N6106ba342f194cefbe8063e4ead3b396 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Body Temperature
146 rdf:type schema:DefinedTerm
147 N6200e302d6c94156a308cba3ec2d04f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antifibrinolytic Agents
149 rdf:type schema:DefinedTerm
150 N6fdebee67fa44aaf84d8f4e569531e59 schema:affiliation grid-institutes:grid.411220.4
151 schema:familyName Martín
152 schema:givenName Beatriz
153 rdf:type schema:Person
154 N72a264d6b85f42049dc89809a6031606 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Creatine Kinase, MB Form
156 rdf:type schema:DefinedTerm
157 N7657580b204043c980bfb7e81558fbe0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Statistics, Nonparametric
159 rdf:type schema:DefinedTerm
160 N7f3b60b95ef84395b630ed223142acd4 rdf:first sg:person.01262262305.35
161 rdf:rest Nb452a1cda23b4cc59662fed5da3acf34
162 N8d2da3d3b53b4505b8a59b641a36408c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Fibrinolysis
164 rdf:type schema:DefinedTerm
165 N90105f56b16343dfbad55f0086ef2fac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Analysis of Variance
167 rdf:type schema:DefinedTerm
168 N97e84c5bee1f4e2bb538c199f3c57f88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Double-Blind Method
170 rdf:type schema:DefinedTerm
171 N9a9d7d1c68124440924cc2877474ddc9 rdf:first sg:person.011703116655.56
172 rdf:rest N42811ae879824b65a30e014fad757490
173 Na2945c88025b43cf80431adf38cddbf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Lactic Acid
175 rdf:type schema:DefinedTerm
176 Naa36c2127adb493fb6da0770eefb8912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Inflammation Mediators
178 rdf:type schema:DefinedTerm
179 Nae041eedf4de4649b5904f4e300d7326 schema:name pubmed_id
180 schema:value 21999189
181 rdf:type schema:PropertyValue
182 Naffadebc55ab4be781f60b8a43b2b052 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Interleukin-6
184 rdf:type schema:DefinedTerm
185 Nb193b71e226f47a09ccf2dbb855d29e4 schema:name doi
186 schema:value 10.1186/1749-8090-6-138
187 rdf:type schema:PropertyValue
188 Nb3330eecb3084a99986335874fab95bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Placebos
190 rdf:type schema:DefinedTerm
191 Nb452a1cda23b4cc59662fed5da3acf34 rdf:first sg:person.01025307027.11
192 rdf:rest Ndc2d9af4e8f647fa816699571785cf92
193 Nceff78bc3b7549f786f88fefc2f39cdc rdf:first sg:person.01076143405.37
194 rdf:rest N9a9d7d1c68124440924cc2877474ddc9
195 Nd1ea0907227d4023a0667d7900ce1514 rdf:first sg:person.0770012723.00
196 rdf:rest rdf:nil
197 Ndb405738fb7e4be7addb5f6ad4e520c8 rdf:first N6fdebee67fa44aaf84d8f4e569531e59
198 rdf:rest N0d92f5e3e9ad497cb39133fc3dcaedc1
199 Ndc2d9af4e8f647fa816699571785cf92 rdf:first sg:person.01100400223.37
200 rdf:rest N02a7e4f79166423a840f70b8a2451964
201 Ndd1554f9b9ee4ef0821bbbec7eff189a rdf:first sg:person.011717357023.49
202 rdf:rest Nd1ea0907227d4023a0667d7900ce1514
203 Nee214c85161a4a0ab161fb64ef6e1cb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Norepinephrine
205 rdf:type schema:DefinedTerm
206 Nf22c064d18db497a9f73462ec909e1c9 schema:name Springer Nature - SN SciGraph project
207 rdf:type schema:Organization
208 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
209 schema:name Medical and Health Sciences
210 rdf:type schema:DefinedTerm
211 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
212 schema:name Clinical Sciences
213 rdf:type schema:DefinedTerm
214 sg:journal.1036453 schema:issn 1749-8090
215 schema:name Journal of Cardiothoracic Surgery
216 schema:publisher Springer Nature
217 rdf:type schema:Periodical
218 sg:person.01025307027.11 schema:affiliation grid-institutes:grid.411220.4
219 schema:familyName Jiménez
220 schema:givenName Alejandro
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025307027.11
222 rdf:type schema:Person
223 sg:person.01076143405.37 schema:affiliation grid-institutes:grid.411220.4
224 schema:familyName Jiménez
225 schema:givenName Juan J
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076143405.37
227 rdf:type schema:Person
228 sg:person.01100400223.37 schema:affiliation grid-institutes:grid.411220.4
229 schema:familyName Lorente
230 schema:givenName Leonardo
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100400223.37
232 rdf:type schema:Person
233 sg:person.011703116655.56 schema:affiliation grid-institutes:grid.411220.4
234 schema:familyName Iribarren
235 schema:givenName José L
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011703116655.56
237 rdf:type schema:Person
238 sg:person.011717357023.49 schema:affiliation grid-institutes:grid.411220.4
239 schema:familyName Martínez
240 schema:givenName Rafael
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011717357023.49
242 rdf:type schema:Person
243 sg:person.01255357701.67 schema:affiliation grid-institutes:grid.411220.4
244 schema:familyName Pérez
245 schema:givenName Rosalía
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255357701.67
247 rdf:type schema:Person
248 sg:person.01256166004.37 schema:affiliation grid-institutes:grid.411220.4
249 schema:familyName Raya
250 schema:givenName José M
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256166004.37
252 rdf:type schema:Person
253 sg:person.01262262305.35 schema:affiliation grid-institutes:grid.411220.4
254 schema:familyName Palmero
255 schema:givenName Salomé
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262262305.35
257 rdf:type schema:Person
258 sg:person.01317135435.05 schema:affiliation grid-institutes:grid.411457.2
259 schema:familyName Hernández
260 schema:givenName Domingo
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01317135435.05
262 rdf:type schema:Person
263 sg:person.01323473101.00 schema:affiliation grid-institutes:grid.411220.4
264 schema:familyName Brouard
265 schema:givenName Maitane
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323473101.00
267 rdf:type schema:Person
268 sg:person.0624762302.45 schema:affiliation grid-institutes:grid.411220.4
269 schema:familyName Machado
270 schema:givenName Patricia
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624762302.45
272 rdf:type schema:Person
273 sg:person.0673075502.74 schema:affiliation grid-institutes:grid.411220.4
274 schema:familyName Borreguero
275 schema:givenName Juan M
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673075502.74
277 rdf:type schema:Person
278 sg:person.0770012723.00 schema:affiliation grid-institutes:grid.411220.4
279 schema:familyName Mora
280 schema:givenName María L
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770012723.00
282 rdf:type schema:Person
283 sg:pub.10.1007/s00134-006-0478-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009668800
284 https://doi.org/10.1007/s00134-006-0478-x
285 rdf:type schema:CreativeWork
286 sg:pub.10.1186/cc6173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051032275
287 https://doi.org/10.1186/cc6173
288 rdf:type schema:CreativeWork
289 sg:pub.10.1186/cc8153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027376444
290 https://doi.org/10.1186/cc8153
291 rdf:type schema:CreativeWork
292 sg:pub.10.1186/cc9216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008087528
293 https://doi.org/10.1186/cc9216
294 rdf:type schema:CreativeWork
295 sg:pub.10.2165/00003495-199957060-00017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008076201
296 https://doi.org/10.2165/00003495-199957060-00017
297 rdf:type schema:CreativeWork
298 grid-institutes:grid.411220.4 schema:alternateName Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
299 Cardiac Surgery Department, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Tenerife, Spain
300 Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
301 Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
302 Mixed Research Unit, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
303 schema:name Biochemical laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
304 Cardiac Surgery Department, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Tenerife, Spain
305 Critical Care Department. Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
306 Hematology Laboratory, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
307 Mixed Research Unit, Hospital Universitario de Canarias, Ofra s/n, La Cuesta, 38320, La Laguna, Spain
308 rdf:type schema:Organization
309 grid-institutes:grid.411457.2 schema:alternateName Nephrology Department, Hospital Universitario Carlos Haya, 29010, Málaga, Spain
310 schema:name Nephrology Department, Hospital Universitario Carlos Haya, 29010, Málaga, Spain
311 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...